Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02896855
Brief Title: A Study to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel Versus Placebo + Trastuzumab + Docetaxel in Previously Untreated Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC)

First Submitted : September 7, 2016
First Submitted that Met QC Criteria : September 7, 2016
First Posted : September 12, 2016 (Estimate)

Results First Submitted : June 18, 2019
Results First Submitted that Met QC Criteria : June 18, 2019
Results First Posted : July 10, 2019

Last Update Submitted that Met QC Criteria : September 16, 2019
Last Update Posted : September 18, 2019